Phathom Pharmaceuticals will announce its third quarter 2026 financial results and provide a business update on October 29, 2026, at 8:00 am EDT via a live webcast. The company focuses on gastrointestinal disease treatments and markets VOQUEZNA®, a drug for GERD and H. pylori infections in adults. Investors can access the webcast on Phathom's website, with a recording available for 90 days after the call. This update is important as it will provide insights into the company's financial health and progress with its novel GI treatments.
Phathom Pharmaceuticals is set to report its Q3 2026 financial results and business update. For readers following the Health sector, here is Pluang's market snapshot as of Oct 19, 2026 18:01 WIB: out of 150 priced US Health stocks, 73 rose and 47 fell. Notable movers include AMLX at USD 26.86 (+1.97%), RLAY at USD 16.59 (+1.90%), and BFLY at USD 7.38 (+1.86%).
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
XBiotech announced positive results from the Phase II TASKIN trial, where their antibody vilamakitug combined with standard chemotherapy improved 12-month overall survival to 61.3% in refractory metastatic colorectal cancer patients, surpassing the s...
Proof and Circle Internet Group demonstrated a new system where AI agents can prove the identity of the person they represent using Proof's x401 open identity protocol and pay merchants in USDC via Circle's x402 payment protocol. This innovation addr...
